U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 20

1.

CGH profiles of sporadic breast tumors

(Submitter supplied) Genomic DNA from sporadic breast tumours was isolated and analysed using array CGH. The NKI 1MB BAC/PAC micro array was used to identify chromosomal aberrations of all tumours. Keywords: sporadic breast tumour, CGH
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4560
47 Samples
Download data: TXT
Series
Accession:
GSE9114
ID:
200009114
2.

CGH profiles of primary breast carcinomas from HBOC (Hereditary Breast and Ovarian Cancer) families

(Submitter supplied) 89 tumors from women that were eligible for, and subjected to, routine diagnostic testing according to the HBOC criteria but were negative for pathogenic BRCA1/2-mutations or carried an UV in either BRCA1/2
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4560
89 Samples
Download data: TXT
Series
Accession:
GSE22481
ID:
200022481
3.

CGH profiles of BRCA2-mutated breast tumors

(Submitter supplied) Prediction of BRCA2-association in hereditary breast carcinomas with array-CGH
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4560
47 Samples
Download data: TXT
Series
Accession:
GSE16511
ID:
200016511
4.

CGH profiles of sporadic basal-like breast tumors

(Submitter supplied) Genomic DNA from sporadic breast tumours was isolated and analysed using array CGH. The NKI 1MB BAC/PAC micro array was used to identify chromosomal aberrations of all tumours. Other profiles are located at: GSE9114 Keywords: sporadic breast tumour, CGH.
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4560
26 Samples
Download data: TXT
Series
Accession:
GSE22401
ID:
200022401
5.

CGH profiles of BRCA1-mutated tumors

(Submitter supplied) While new defects in BRCA1 are still being found, it is unclear whether current breast cancer diagnostics misses many BRCA1-associated cases. A reliable test that is able to indicate the involvement of BRCA1 deficiency in cancer genesis could support decision making in genetic counselling and clinical management. To find BRCA1-specific markers and explore the effectiveness of the current diagnostic strategy, we designed a classification method, validated it and examined whether we could find BRCA1-like breast tumours in a group of patients initially diagnosed as non-BRCA1/2 mutation carriers. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4560
37 Samples
Download data: TXT
Series
Accession:
GSE9021
ID:
200009021
6.

Subtypes of familial breast tumors revealed by expression and copy number profiling

(Submitter supplied) We analysed a cohort of 75 BRCA1, BRCA2 and non-BRCA1/2 breast tumors by gene expression profiling and found that 74% BRCA1 tumors were basal-like, 73% of BRCA2 tumors were luminal A or B, and 52% non-BRCA1/2 tumors were luminal A. Thirty-four tumors were also analysed by single nucleotide polymorphism-comparative genomic hybridization (SNP-CGH) arrays. Copy number data could predict whether a tumor was basal-like or luminal with high accuracy, but could not predict its mutation class. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome variation profiling by SNP array; SNP genotyping by SNP array
Platforms:
GPL6986 GPL6106
109 Samples
Download data: TXT
Series
Accession:
GSE19177
ID:
200019177
7.

Determination of molecular markers for BRCA1 and BRCA2 heterozygosity using gene expression profiling

(Submitter supplied) Approximately 5% of all breast cancers can be attributed to an inherited mutation in one of two cancer susceptibility genes, BRCA1 and BRCA2. We searched for genes that have the potential to distinguish healthy BRCA1 and BRCA2 mutation carriers from non-carriers based on differences in expression profiling. Using expression microarrays we compared gene expression of irradiated lymphocytes from BRCA1 and BRCA2 mutation carriers versus control non-carriers. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL571
26 Samples
Download data: CEL
Series
Accession:
GSE39976
ID:
200039976
8.

Comparative genomic hybridization of BRCAX breast tumors

(Submitter supplied) Only about 25% of familial breast cancer is explained by mutations in BRCA1 and BRCA2, fewer by moderate penetrance genes like P53, PTEN, CHEK2, ATM and PALB2 and an unknown fraction by common variants of genes with low penetrance. Evidence suggests that additional dominant breast cancer genes exist and these are referred to as BRCAX. Clinical presentation of families with highly increased incidence of breast cancer that are non-BRCA1/BRCA2, suggests dominant inheritance of such high penetrance breast cancer genes. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by array
Platform:
GPL4560
106 Samples
Download data: TXT
Series
Accession:
GSE18626
ID:
200018626
9.

Molecular genomic and transcriptomic profiling of familial breast cancer.

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome variation profiling by SNP array
Platforms:
GPL570 GPL3720 GPL3718
395 Samples
Download data: CEL
Series
Accession:
GSE54219
ID:
200054219
10.

Proper genomic profiling of (BRCA1-mutated) basal-like breast carcinomas requires prior removal of tumor infiltrating lymphocytes

(Submitter supplied) To find BRCA1-associated copy number abberations, the copy number profiles of Familial Basal-like BRCA1-mutated breast carcinomas were compared to Familial Basal-like carcinomas with no pathgogenic BRCA1/2 mutation. This led to the observation of unanticipated heterogeneity of the BRCA1 associated copy number profiles. Gene expression analysis on the same samples identified tumor infiltrating lymphocytes to be responsible for this observation. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platforms:
GPL3718 GPL3720
240 Samples
Download data: CEL
Series
Accession:
GSE54193
ID:
200054193
11.

Expression data from primary breast tumors

(Submitter supplied) CHEK2 1100delC is a moderate-risk cancer susceptibility allele that confers a high breast cancer risk in a polygenic setting. Gene expression profiling of CHEK2 1100delC breast cancers may reveal clues to the nature of the polygenic CHEK2 model and its genes involved. Here, we report global gene expression profiles of a cohort of 155 familial breast cancers, including 26 CHEK2 1100delC mutant tumors. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL570
155 Samples
Download data: CEL
Series
Accession:
GSE27830
ID:
200027830
12.

The retinoblastoma gene is targeted for rearrangements in BRCA1-deficient basal-like breast cancer.

(Submitter supplied) Breast tumors from BRCA1 germ line mutation carriers typically exhibit features of the basal-like molecular subtype. However, the specific genes recurrently mutated as a consequence of BRCA1 dysfunction have not been fully elucidated. In this study, we utilized gene expression profiling to molecularly subtype 577 breast tumors, including 73 breast tumors from BRCA1/2 mutation carriers. Focusing on the RB1 locus, we analyzed 33 BRCA1-mutated, 36 BRCA2-mutated and 48 non-BRCA1/2-mutated breast tumors using a custom-designed high-density oligomicroarray covering the RB1 gene. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5345
577 Samples
Download data: GPR, TXT
Series
Accession:
GSE25307
ID:
200025307
13.

Genomic profiling of Estrogen receptor positive BRCA1-mutated breast cancer

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platforms:
GPL17641 GPL4560
16 Samples
Download data: PAIR, TXT
Series
Accession:
GSE77605
ID:
200077605
14.

Genomic profiling of Estrogen receptor positive BRCA1-mutated breast cancer [human 3.5k BAC array]

(Submitter supplied) Purpose: As estrogen receptor (ER)-positive breast cancer in BRCA1 mutation carriers arises at an older age with less aggressive tumor characteristics than ER negative BRCA1 mutated breast cancer, it has been suggested that these tumors are ?sporadic? and not BRCA1-driven. With the introduction of targeted treatments specific for tumors with a non-functioning BRCA1 or BRCA2 gene, the question whether the BRCA genes are impaired in the tumor, is highly relevant. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL4560
3 Samples
Download data: TXT
Series
Accession:
GSE77604
ID:
200077604
15.

Genomic profiling of Estrogen receptor positive BRCA1-mutated breast cancer [Nimblegen human 135K]

(Submitter supplied) Purpose: As estrogen receptor (ER)-positive breast cancer in BRCA1 mutation carriers arises at an older age with less aggressive tumor characteristics than ER negative BRCA1 mutated breast cancer, it has been suggested that these tumors are ?sporadic? and not BRCA1-driven. With the introduction of targeted treatments specific for tumors with a non-functioning BRCA1 or BRCA2 gene, the question whether the BRCA genes are impaired in the tumor, is highly relevant. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL17641
13 Samples
Download data: PAIR
Series
Accession:
GSE77603
ID:
200077603
16.

OncoScan analysis to investigate CNV in breast tumors developed by ATM mutation carriers

(Submitter supplied) The ataxia telangiectasia-mutated (ATM) gene is a moderate-risk breast cancer susceptibility gene; germline loss-of-function variants are found in up to 3% of hereditary breast and ovarian cancer (HBOC) families who undergo genetic testing. So far, no clear molecular features of breast tumors occuring in ATM deleterious variant carriers have been described, but identification of an ATM-associated tumors signature may help patients' management. more...
Organism:
Homo sapiens
Type:
Genome variation profiling by SNP array
Platforms:
GPL18602 GPL21558
46 Samples
Download data: CEL, XLS
Series
Accession:
GSE111711
ID:
200111711
17.

Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

(Submitter supplied) Pathogenic germline mutations in BRCA1 or BRCA2 are detected in less than one third of families with a strong history of breast cancer. It is therefore expected that mutations still remain undetected by currently used screening methods. In addition, a growing number of BRCA1/2 sequence variants of unclear pathogen significance are found in the families, constituting an increasing clinical challenge. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platforms:
GPL15932 GPL15931
275 Samples
Download data: GPR, TXT
Series
Accession:
GSE40115
ID:
200040115
18.

Male breast cancer copy number profiles

(Submitter supplied) Exploratory study of copy number profiles of male breast cancer patients.
Organism:
Homo sapiens
Type:
Genome variation profiling by genome tiling array
Platform:
GPL17641
75 Samples
Download data: PAIR
Series
Accession:
GSE57087
ID:
200057087
19.

Genomic Subtypes of Breast Cancer Identified by Array Comparative Genomic Hybridization

(Submitter supplied) Breast cancer is a profoundly heterogeneous disease with respect to biological and clinical behavior. Gene expression profiling has been used to dissect this complexity and stratify tumors into intrinsic gene expression subtypes associated with distinct biology, patient outcome and different genomic alterations. Additionally, breast tumors occurring in individuals with germline BRCA1 or BRCA2 mutations typically fall into distinct subtypes. more...
Organism:
Homo sapiens
Type:
Expression profiling by array; Genome variation profiling by array
Platforms:
GPL4723 GPL5345 GPL7247
718 Samples
Download data: GPR, TXT
Series
Accession:
GSE22133
ID:
200022133
20.

RNA Profiles Reveals Familial Aggregation of Molecular Subtypes in non-BRCA1/2 Breast Cancer Families

(Submitter supplied) In more than 70% of families with a strong history of breast and ovarian cancers, pathogenic mutation in BRCA1 or BRCA2 cannot be identified, even though hereditary factors are expected to be involved. It has been proposed that tumors with similar molecular phenotypes also share similar pathophysiological mechanisms. Grouping into molecularly homogeneous subsets may therefore be of potential value for further genetic analysis in order to identify new high penetrance breast cancer genes. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL15931
253 Samples
Download data: TXT
Series
Accession:
GSE49481
ID:
200049481
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=2|blobid=MCID_674ccc9ff363504c2f31ad6e|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center